Cargando…

Studies of Inhibitory Mechanisms of Propeptide-Like Cysteine Protease Inhibitors

Mouse cytotoxic T-lymphocyte antigen-2α (CTLA-2α), Drosophila CTLA-2-like protein (crammer), and Bombyx cysteine protease inhibitor (BCPI) belong to a novel family of cysteine protease inhibitors (I29). Their inhibitory mechanisms were studied comparatively. CTLA-2α contains a cysteine residue (C75)...

Descripción completa

Detalles Bibliográficos
Autores principales: Nga, Bui T. T., Takeshita, Yuki, Yamamoto, Misa, Yamamoto, Yoshimi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4089206/
https://www.ncbi.nlm.nih.gov/pubmed/25045530
http://dx.doi.org/10.1155/2014/848937
_version_ 1782325085489594368
author Nga, Bui T. T.
Takeshita, Yuki
Yamamoto, Misa
Yamamoto, Yoshimi
author_facet Nga, Bui T. T.
Takeshita, Yuki
Yamamoto, Misa
Yamamoto, Yoshimi
author_sort Nga, Bui T. T.
collection PubMed
description Mouse cytotoxic T-lymphocyte antigen-2α (CTLA-2α), Drosophila CTLA-2-like protein (crammer), and Bombyx cysteine protease inhibitor (BCPI) belong to a novel family of cysteine protease inhibitors (I29). Their inhibitory mechanisms were studied comparatively. CTLA-2α contains a cysteine residue (C75), which is essential for its inhibitory potency. The CTLA-2α monomer was converted to a disulfide-bonded dimer in vitro and in vivo. The dimer was fully inhibitory, but the monomer, which possessed a free thiol residue, was not. A disulfide-bonded CTLA-2α/cathepsin L complex was isolated, and a cathepsin L subunit with a molecular weight of 24,000 was identified as the interactive enzyme protein. Crammer also contains a cysteine residue (C72). Both dimeric and monomeric forms of crammer were inhibitory. A crammer mutant with Cys72 to alanine (C72A) was fully inhibitory, while the replacement of Gly73 with alanine (G73A) caused a significant loss in inhibitory potency, which suggests a different inhibition mechanism from CTLA-2α. BCPI does not contain cysteine residue. C-terminal region (L77-R80) of BCPI was essential for its inhibitory potency. CTLA-2α was inhibitory in the acidic pH condition but stabilized cathepsin L under neutral pH conditions. The different inhibition mechanisms and functional considerations of these inhibitors are discussed.
format Online
Article
Text
id pubmed-4089206
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-40892062014-07-20 Studies of Inhibitory Mechanisms of Propeptide-Like Cysteine Protease Inhibitors Nga, Bui T. T. Takeshita, Yuki Yamamoto, Misa Yamamoto, Yoshimi Enzyme Res Research Article Mouse cytotoxic T-lymphocyte antigen-2α (CTLA-2α), Drosophila CTLA-2-like protein (crammer), and Bombyx cysteine protease inhibitor (BCPI) belong to a novel family of cysteine protease inhibitors (I29). Their inhibitory mechanisms were studied comparatively. CTLA-2α contains a cysteine residue (C75), which is essential for its inhibitory potency. The CTLA-2α monomer was converted to a disulfide-bonded dimer in vitro and in vivo. The dimer was fully inhibitory, but the monomer, which possessed a free thiol residue, was not. A disulfide-bonded CTLA-2α/cathepsin L complex was isolated, and a cathepsin L subunit with a molecular weight of 24,000 was identified as the interactive enzyme protein. Crammer also contains a cysteine residue (C72). Both dimeric and monomeric forms of crammer were inhibitory. A crammer mutant with Cys72 to alanine (C72A) was fully inhibitory, while the replacement of Gly73 with alanine (G73A) caused a significant loss in inhibitory potency, which suggests a different inhibition mechanism from CTLA-2α. BCPI does not contain cysteine residue. C-terminal region (L77-R80) of BCPI was essential for its inhibitory potency. CTLA-2α was inhibitory in the acidic pH condition but stabilized cathepsin L under neutral pH conditions. The different inhibition mechanisms and functional considerations of these inhibitors are discussed. Hindawi Publishing Corporation 2014 2014-06-19 /pmc/articles/PMC4089206/ /pubmed/25045530 http://dx.doi.org/10.1155/2014/848937 Text en Copyright © 2014 Bui T. T. Nga et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Nga, Bui T. T.
Takeshita, Yuki
Yamamoto, Misa
Yamamoto, Yoshimi
Studies of Inhibitory Mechanisms of Propeptide-Like Cysteine Protease Inhibitors
title Studies of Inhibitory Mechanisms of Propeptide-Like Cysteine Protease Inhibitors
title_full Studies of Inhibitory Mechanisms of Propeptide-Like Cysteine Protease Inhibitors
title_fullStr Studies of Inhibitory Mechanisms of Propeptide-Like Cysteine Protease Inhibitors
title_full_unstemmed Studies of Inhibitory Mechanisms of Propeptide-Like Cysteine Protease Inhibitors
title_short Studies of Inhibitory Mechanisms of Propeptide-Like Cysteine Protease Inhibitors
title_sort studies of inhibitory mechanisms of propeptide-like cysteine protease inhibitors
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4089206/
https://www.ncbi.nlm.nih.gov/pubmed/25045530
http://dx.doi.org/10.1155/2014/848937
work_keys_str_mv AT ngabuitt studiesofinhibitorymechanismsofpropeptidelikecysteineproteaseinhibitors
AT takeshitayuki studiesofinhibitorymechanismsofpropeptidelikecysteineproteaseinhibitors
AT yamamotomisa studiesofinhibitorymechanismsofpropeptidelikecysteineproteaseinhibitors
AT yamamotoyoshimi studiesofinhibitorymechanismsofpropeptidelikecysteineproteaseinhibitors